| Mifeprex (mifepristone) / Danco Laboratories |
ChiCTR-IOR-15007664: A randomized clinical trial comparing the efficacy of drug and artificial abortion. |
|
|
| Not yet recruiting | N/A | 200 | | mifepristone and misoprostol ;Curettage | Reproductive Hospital Affiliated to Shandong University; Reproductive Hospital Affiliated to Shandong University, hospital funding | arrested pregnancy with 14 week's gestation | | | | |
ChiCTR-INR-17014174: Effect of GnRH- antagonist combined with mifepristone and letrozole on early-onset ovarian hyperstimulation syndrome in high-risk women: a prospective randomized controlled study |
|
|
| Recruiting | N/A | 152 | | combination of GnRH - A and letrozole with mifepristone will be used for High-risk early-onset OHSS patients after oocyte retrieval ;mifepristone will be used for High-risk early-onset OHSS patients after oocyte retrieval | International Affairs Office, Wuhan University Renmin Hospital (Hubei General Hospital); International Affairs Office, Wuhan University Renmin Hospital (Hubei General Hospital), self-financing | Ovarian hyperstimulation syndrome | | | | |
ChiCTR2100046503: Analysis on the etiology and outcome of missed abortion caused by uterine environment |
|
|
| Recruiting | N/A | 96 | | Mifepristone combined with estradiol valerate ;Estradiol valerate ;Mifepristone ;Basic medicine | The First Affiliated Hospital of Chongqing Medical University; The First Affiliated Hospital of Chongqing Medical University, NO | Early pregnancy loss | | | | |
NCT03440866: Comparison of the Effectiveness of Treatment With Mifepristone and Misoprostol at the Same Time Compared to the Administration of Drugs at a 48-hour Interval for Medical Abortion. |
|
|
| Active, not recruiting | N/A | 250 | RoW | Administration of drugs concomitantly., no interval | HaEmek Medical Center, Israel | Early Pregnancy | 12/21 | 12/23 | | |
NCT04271722: Clinical Evaluation of Cervical Ripening in the Outpatient Setting |
|
|
| Completed | N/A | 101 | Europe | Cervical ripening | Centro Hospitalar Lisboa Norte | Labor; Forced or Induced, Affecting Fetus or Newborn, Labor Onset and Length Abnormalities | 12/22 | 12/22 | | |
HYMMN, NCT04751500: The HYsteroscopic Miscarriage MaNagement Trial: A Pilot RCT Investigating a Novel Management Pathway for RPOC |
|
|
| Completed | N/A | 149 | Europe | Outpatient hysteroscopy, Expectant management, Medical management, misoprostol, mifepristone, Antibiotic, Augmentin, Co-amoxiclav, Metronidazole, Clindamycin, Surgical management, manual vacuum aspiration, suction evacuation of the uterus, dilatation and currettage | Birmingham Women's and Children's NHS Foundation Trust, Tommy's | Retained Products After Miscarriage | 11/22 | 11/22 | | |
| Completed | N/A | 306 | Europe | scale of pain | Assistance Publique Hopitaux De Marseille | Abortion-Related Disorders | 03/23 | 04/23 | | |
ChiCTR2200061298: Clinical study of low dose mifepristone combined with high intensity focused ultrasound in the treatment of uterine fibroids |
|
|
| Recruiting | N/A | 100 | | Oral mifepristone for 3 months ;No | Affiliated Hospital of North Sichuan Medical College; Affiliated Hospital of North Sichuan Medical College, individual | uterine fibroids | | | | |
MiMAC, NCT04905251: Effectiveness and Safety of Combination Mifepristone/Misoprostol for Medical Abortion |
|
|
| Recruiting | N/A | 3000 | Canada | Mifepristone-Misoprostol | Linepharma International LTD | Medical Abortion | 06/23 | 12/23 | | |
IMEGYN, NCT03194126: Evaluation of Efficacy of Two Therapeutic Strategies for Cervical Maturation Before Medical Termination |
|
|
| Completed | N/A | 120 | Europe | Mifepristone + Misoprostol OR oxytocine + laminaria, Mifepristone + Misoprostol OR oxytocine | Centre Hospitalier Universitaire de Nīmes | Medical; Abortion, Fetus | 09/23 | 09/23 | | |
ChiCTR2200065595: Exploratory Clinical Study on Mifepristone for the Treatment of Recurrent Glioblastoma |
|
|
| Not yet recruiting | N/A | 20 | | Administration of Mifepristone | Huashan Hospital, Fudan University; Huashan Hospital, Self Funding | Recurrent Glioblastoma | | | | |
TCRM, NCT05898321: To Prevent Type I-II Myoma After Recurrence by Gonadotropin-releasing Hormone (GnRH )Analogues or Mifepristone |
|
|
| Not yet recruiting | N/A | 294 | RoW | Zoladex, Mifepristone Oral Tablet | Women's Hospital School Of Medicine Zhejiang University | Submucous Leiomyoma of Uterus | 12/24 | 12/25 | | |
